tedisamil has been researched along with Coronary Heart Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 7 (77.78) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bargheer, K; Bode, F; Franz, MR; Klein, HU; Lichtlen, PR; Trappe, HJ | 1 |
| Bahavar, H; Mitrovic, V; Neuzner, J; Riedel, H; Schlepper, M; Strasser, R; Thormann, J | 1 |
| Bahavar, H; Mitrovic, V; Pitschner, HF; Riedel, H; Schlepper, M; Strasser, R; Thormann, J | 1 |
| Mitrovic, V; Oehm, E; Pitschner, HF; Schlepper, M; Strasser, R | 1 |
| Haberbosch, W; Mitrovic, V; Oehm, E; Pitschner, H; Thormann, J | 1 |
| Hamm, C; Mitrovic, V; Oehm, E; Pitschner, H; Thormann, J | 1 |
| Curtis, MJ; Tsuchihashi, K | 1 |
| Abraham, S; Beatch, GN; MacLeod, BA; Walker, MJ; Yoshida, NR | 1 |
| Fischer, G; Grohs, JG; Raberger, G | 1 |
4 trial(s) available for tedisamil and Coronary Heart Disease
| Article | Year |
|---|---|
Tedisamil (KC 8857) is a new specific bradycardic drug: does it also influence myocardial contractility? Analysis by the conductance (volume) technique in coronary artery disease.
Topics: Aged; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cardiotonic Agents; Coronary Disease; Cyclopropanes; Depression, Chemical; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Ventricular Function | 1993 |
[The new potassium channel blocker tedisamil and its hemodynamic, anti-ischemic and neurohumoral effect in patients with coronary heart disease].
Topics: Aged; Bridged Bicyclo Compounds, Heterocyclic; Cardiac Catheterization; Cardiotonic Agents; Coronary Circulation; Coronary Disease; Cyclopropanes; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Potassium Channels | 1996 |
Comparison of the potassium channel blocker tedisamil with the beta-adrenoceptor blocker esmolol and the calcium antagonist gallopamil in patients with coronary artery disease.
Topics: Adrenergic beta-Antagonists; Blood Gas Analysis; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Catecholamines; Coronary Disease; Cyclopropanes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Female; Gallopamil; Hemodynamics; Humans; Lactic Acid; Male; Middle Aged; Potassium Channel Blockers; Propanolamines; Treatment Outcome | 1998 |
Potassium channel openers and blockers in coronary artery disease. Comparison to betablockers and calcium antagonists.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Analysis of Variance; Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Benzopyrans; Bridged Bicyclo Compounds, Heterocyclic; Calcium Channel Blockers; Cardiotonic Agents; Coronary Disease; Cyclopropanes; Dihydropyridines; Electrocardiography; Exercise Test; Gallopamil; Hemodynamics; Humans; Middle Aged; Myocardium; Oxygen Consumption; Potassium Channel Blockers; Potassium Channels; Propanolamines; Time Factors; Vasodilator Agents | 2000 |
5 other study(ies) available for tedisamil and Coronary Heart Disease
| Article | Year |
|---|---|
Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent.
Topics: Action Potentials; Anti-Arrhythmia Agents; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cardiac Pacing, Artificial; Coronary Disease; Cyclopropanes; Electrocardiography; Female; Heart Conduction System; Humans; Infusions, Intravenous; Male; Middle Aged; Potassium Channel Blockers; Ventricular Function, Left | 1994 |
[Is the bradycardic effect of tedisamil at the expense of the loss of the inotropic effect? A pressure-volume analysis with the conductance (volume) catheter technique in patients with coronary artery disease].
Topics: Aged; Anti-Arrhythmia Agents; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cardiac Catheterization; Cardiac Output; Cardiac Pacing, Artificial; Cardiotonic Agents; Coronary Disease; Cyclopropanes; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Ventricular Function, Left | 1993 |
Influence of tedisamil on the initiation and maintenance of ventricular fibrillation: chemical defibrillation by Ito blockade?
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cardiac Pacing, Artificial; Coronary Disease; Cyclopropanes; Electrocardiography; Electrophysiology; In Vitro Techniques; Male; Myocardial Reperfusion; Perfusion; Rats; Rats, Inbred Strains; Ventricular Fibrillation | 1991 |
Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arterial Occlusive Diseases; Blood Pressure; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Coronary Disease; Cyclopropanes; Dose-Response Relationship, Drug; Electric Stimulation; Electrocardiography; Heart; Heart Rate; Male; Myocardial Infarction; Potassium Channels; Rats; Rats, Inbred Strains; Refractory Period, Electrophysiological; Ventricular Fibrillation | 1991 |
Cardiac and hemodynamic effects of the selective bradycardic agent KC 8857 during exercise-induced myocardial ischemia.
Topics: Animals; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Bridged-Ring Compounds; Cardiotonic Agents; Coronary Disease; Cyclopropanes; Dogs; Heart; Heart Rate; Hemodynamics; Myocardial Contraction; Myocardium; Oxygen Consumption; Physical Exertion | 1989 |